Skip to main content
Clinical Trials/ITMCTR2200006576
ITMCTR2200006576
Not yet recruiting
Phase 1

Study on The Intervention Effect on Patients with Dyslipidemia of Dampness Syndrome

Guangdong Provincial Hospital of Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Guangdong Provincial Hospital of Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Guangdong Provincial Hospital of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\.18\-70 years old.
  • 2\.Those who meet the typical diagnosis of dampness syndrome in the Diagnostic Standard of Dampness Syndrome of Traditional Chinese Medicine V2\.0\.
  • 3\.Those who meet the diagnosis of dyslipidemia in the guidelines for Prevention and Treatment of Dyslipidemia in Chinese Adults (2016 revised Edition).
  • 4\.Patients whose cardiovascular risk assessment is medium risk and low risk.
  • 5\.Those who volunteer to participate in the study of this subject and sign informed consent forms.

Exclusion Criteria

  • 1\. Patients with nephrotic syndrome, hypothyroidism, renal failure, liver disease, systemic lupus erythematosus, myeloma, glycogen accumulation, lipoatrophy, acute porphyria and polycystic ovary syndrome.
  • 2\. Patients who are using drugs related to blood lipid metabolism, such as diuretics, beta blockers, glucocorticoids, metformin, insulin, contraceptive.
  • 3\. Patients with systolic blood pressure \= 180mmHg or diastolic blood pressure \= 110mHg after treatment.
  • 4\. Patients whose fasting blood glucose was still \= 11\.1mmol/L after oral drug treatment.
  • 5\. Patients whose TG \= 5\.65mmol/L.
  • 6\. Patients with systemic severe diseases such as heart, liver, kidney, hematopoietic system, immune system, etc.
  • 7\. Pregnant or lactating women or people who plan to become pregnant during the trial or whose spouse plans to become pregnant.
  • 8\. Patients with allergic constitution, who may be allergic to this drug or who are mentally ill.
  • 9\. Other patients who can't cooperate for a long time.

Outcomes

Primary Outcomes

Not specified

Similar Trials